Literature DB >> 32697361

Bridging the gap in epilepsy care: A single-center experience of 3700 outpatient tele-epilepsy visits.

Jessica R Fesler1, Susan Stanton1, Kim Merner1, Lindsay Ross2, Marisa P McGinley3, James Bena4, Peter Rasmussen2, Imad Najm1, Vineet Punia1.   

Abstract

We describe the largest-to-date single-center implementation of tele-epilepsy. Beginning in 2017, all patients at a single tertiary care academic epilepsy center were offered the option to complete outpatient follow-up visits via video-conferencing using personal devices. A retrospective review of all patients who self-selected virtual visits over nearly 3 years showed 2140 patients completed 3698 tele-epilepsy visits, with 41% completing more than one visit during the study period. Based on the distance from the center to the home address, 26.7% of patients were local (≤50 miles), 30.5% were near regional (51-150 miles), 20.1% were far regional (151-270 miles), and 22.7% were remote (>270 miles), from 43 different states. An estimated 928 696 miles of travel was prevented, with a median travel distance saved of 124.5 miles (interquartile range = 45.0-253.0). The mean visit time was 15.7 (±10.4) minutes. More than 90% of patients gave the visit and provider experience the maximum rating, with a nearly 60% response rate on the post-visit survey. Virtual outpatient follow-up care provides a convenient way to connect with epilepsy specialists and reduce the burden of care by cutting travel time. Our experience demonstrates that outpatient tele-epilepsy is feasible, sustainable, and scalable.
© 2020 International League Against Epilepsy.

Entities:  

Keywords:  health care delivery; tele-epilepsy; telehealth; telemedicine

Year:  2020        PMID: 32697361     DOI: 10.1111/epi.16619

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial.

Authors:  Nicholas A Streltzov; Samantha S Schmidt; Lindsay M Schommer; Wenyan Zhao; Tor D Tosteson; Morgan T Mazanec; Elaine T Kiriakopoulos; Felicia Chu; Heidi L Henninger; Keith Nagle; Robert M Roth; Barbara Jobst
Journal:  Neurology       Date:  2022-04-06       Impact factor: 11.800

2.  Disparities in Access to Neurologic Telemedicine During the COVID-19 Pandemic: A Bronx Tale.

Authors:  Jonathan M Gursky; Alex Boro; Sheri Escalante; Victor Ferastraoaru; Rajani Hanumanthu; Sheryl Haut; Rana Jehle; Isaac Molinero; Lindsay Rick; Jillian Rosengard; Mohamad Saifeddine; William Sugrue; Solomon L Moshé; Karen Ballaban-Gil
Journal:  Neurol Clin Pract       Date:  2021-04

3.  Long-term analysis of the effects of COVID-19 in people with epilepsy: Results from a multicenter on-line survey across the pandemic waves.

Authors:  Chiara Parodi; Ilaria Viganò; Emerenziana Ottaviano; Valentina Massa; Elisa Borghi; Simone Beretta; Jacopo C Di Francesco; Valeria Badioni; Aglaia Vignoli
Journal:  Epilepsy Behav       Date:  2022-08-25       Impact factor: 3.337

4.  Telehealth for Children With Epilepsy Is Effective and Reduces Anxiety Independent of Healthcare Setting.

Authors:  Kerstin Alexandra Klotz; Felippe Borlot; Morris H Scantlebury; Eric T Payne; Juan Pablo Appendino; Jan Schönberger; Julia Jacobs
Journal:  Front Pediatr       Date:  2021-06-10       Impact factor: 3.418

5.  Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: The patient perspective.

Authors:  Jillian L Rosengard; Jad Donato; Victor Ferastraoaru; Dan Zhao; Isaac Molinero; Alexis Boro; Jonathan Gursky; Daniel José Correa; Aristea S Galanopoulou; Christine Hung; Alan D Legatt; Puja Patel; Elayna Rubens; Solomon L Moshé; Sheryl Haut
Journal:  Epilepsia       Date:  2020-11-30       Impact factor: 6.740

6.  Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic.

Authors:  Proleta Datta; Wattana Barrett; Monica Bentzinger; Tracy Jasinski; Lakshman Arcot Jayagopal; Alexa Mahoney; Crystal Pearon; Arun Swaminathan; Aditya Vuppala; Kaeli K Samson; Hongmei Wang; Olga Taraschenko
Journal:  Epilepsy Behav       Date:  2021-02-02       Impact factor: 2.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.